Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that ...

New findings may help patients with low to moderate risk of tumor lysis syndrome while reducing the burden for hematologists.

A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified ...